GlassScriptPhysician profile
Kelli A Strauss
NPI 1033114244
$555.62
in general payments reported to CMS, 2019-2025
16 companies · $70.77 in 2025
The $70.77 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $71.88 · 2021: $13.34 · 2022: $12.58 · 2023: $113 · 2024: $118 · 2025: $70.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $74.77 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $66.56 | 2019-2025 | Rybelsus, Ozempic, Tresiba |
| Esperion Therapeutics, INC. | $64.08 | 2020-2025 | Nexletol |
| Lilly USA, LLC | $60.00 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $53.09 | 2020-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $42.88 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $31.54 | 2020-2023 | Farxiga |
| Sanofi Pasteur INC. | $29.38 | 2019 | |
| Abbvie INC. | $28.33 | 2021-2024 | |
| Genentech USA, INC. | $18.54 | 2019 | |
| Phathom Pharmaceuticals, INC. | $16.98 | 2024 | Voquezna |
| Exact Sciences Corporation | $16.82 | 2023 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.40 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $12.85 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.10 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Strauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.